Global Migraine with Brainstem Aura Research Report: By Diagnosis (Magnetic Resonance Imaging, Other), by Treatment (Abortive Medication, Other), by Distribution Channel (Retail Pharmacies, Other), End-User (Hospitals & Clinics, Other)– Forecast Till 2027Migraine with brainstem aura is termed for pain at the back of the head.
Migraine is a complex disorder that is developed due to the influence of lifestyle and environmental factors over multiple genes.
As per the Centers for Disease Control and Prevention (CDC), in 2015, about 9.7% of men and 20% of women age 18 years had a migraine.Additionally, Migraine Trust estimated that in 2017 around 2% of the world’s population had chronic migraines.
This surge in several patients and the requirement of advanced treatment have encouraged investment in research and development of newer drugs, which is driving growth of the global migraine with brainstem aura market.Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/6405Moreover, some of the external factors including motion sickness, stress, epilepsy, prolonged hunger, alcoholism, excessive consumption of headache medications triggers several types of migraines.
Changing lifestyle and increasing stress levels and consumption of alcohol among working people are driving growth of the global migraine with brainstem aura market.However, risks of the possible side effects of the drugs taken to the treatment of migraine with brainstem aura such as sleepiness and fatigue, racing heartbeat, nausea, and difficulty in thinking are creating fear among patients, which are restraining growth of the global migraine with brainstem aura market.
Nonetheless, the lack of proper medication for the treatment of disease and robust investment for drug development is likely to offer opportunities for growth in the coming years.